ORIGINAL RESEARCH article
Front. Pediatr.
Sec. Pediatric Pulmonology
Volume 13 - 2025 | doi: 10.3389/fped.2025.1655289
Lipidomics Changes in Bronchoalveolar Lavage Fluid of Refractory Mycoplasma Pneumoniae Pneumonia: LC-MS-based Analysis of Potential Biomarkers and Pathogenesis
Provisionally accepted
- Northwest Women and Children’s Hospital, Xi'an, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
BACKGROUND: Previous studies have reported the application of metabolomics in infectious diseases, but little is known about the potential function of bronchoalveolar lavage fluid (BALF) metabolites in children with (mycoplasma pneumoniae pneumonia) MPP and (refractory mycoplasma pneumoniae pneumonia) RMPP. METHODS: In this study, untargeted lipidomic analysis of BALF in MPP patients (n=14) and RMPP patients (n=14) was performed based on the liquid chromatograph-mass spectrometry (LC-MS) method. Orthogonal Projections to Latent Structures Discriminant Analysis (OPLS-DA) was applied to analyze the resultant dataset. Differential metabolites with variable importance in the projection (VIP) > 1.5, P < 0.05, and |log2FC| > 1 were subjected to multivariate receiver operating characteristic (ROC) analysis to determine the discriminatory power and reliability of potential biomarkers. The potential significance of the differential metabolites was further demonstrated by correlation analysis between the identified differential markers and clinical inflammatory and cardiovascular indicators. RESULTS: Thirteen differential lipids were found between RMPP and MPP, among which there were three significantly up-regulated differential metabolites (DG(34:4e), PC(36:5), SM(d38:3)), and the areas under the curves (AUCs) of all of them were greater than 0.8, and among the up-regulated differential metabolites of lipids between RMPP and MPP, DG(34:4e) and SM(d38:3) were positively correlated with Hydroxybutyrate Dehydrogenase (HBDH), Lactate Dehydrogenase (LDH), Creatine Kinase (CK), D-Dimer, and Fibrin Degradation Products (FDP). CONCLUSION: This is the first study to analyze the lipidomic features of BALF to differentiate between RMPP and MPP. The lipidomics of BALF in patients with RMPP was significantly altered and closely correlated with clinically relevant indicators. These data may contribute to the understanding of the pathogenesis of RMPP and the discovery of new biomarkers and therapeutic targets for RMPP.
Keywords: Children, Mycoplasma pneumoniae, Bronchoalveolar Lavage Fluid, Lipid Metabolism, biomarkers
Received: 02 Jul 2025; Accepted: 03 Sep 2025.
Copyright: © 2025 Ma, Shi, Wang, Huang and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Miao Ma, Northwest Women and Children’s Hospital, Xi'an, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.